ConductScience.org, home

Trial · NCT00619866

Participant flow30

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Weeks 1 - 12STARTEDPlacebo52
Weeks 1 - 12STARTEDElagolix 150 mg51
Weeks 1 - 12STARTEDElagolix 250 mg52
Weeks 1 - 12STARTEDPlacebo / Elagolix 150 mg0
Weeks 1 - 12STARTEDPlacebo / Elagolix 250 mg0
Weeks 1 - 12COMPLETEDPlacebo38
Weeks 1 - 12COMPLETEDElagolix 150 mg45
Weeks 1 - 12COMPLETEDElagolix 250 mg42
Weeks 1 - 12COMPLETEDPlacebo / Elagolix 150 mg0
Weeks 1 - 12COMPLETEDPlacebo / Elagolix 250 mg0
Weeks 1 - 12NOT COMPLETEDPlacebo14
Weeks 1 - 12NOT COMPLETEDElagolix 150 mg6
Weeks 1 - 12NOT COMPLETEDElagolix 250 mg10
Weeks 1 - 12NOT COMPLETEDPlacebo / Elagolix 150 mg0
Weeks 1 - 12NOT COMPLETEDPlacebo / Elagolix 250 mg0
Weeks 13 - 24STARTEDPlacebo0
Weeks 13 - 24STARTEDElagolix 150 mg45
Weeks 13 - 24STARTEDElagolix 250 mg42
Weeks 13 - 24STARTEDPlacebo / Elagolix 150 mg18
Weeks 13 - 24STARTEDPlacebo / Elagolix 250 mg20

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00619866/flow